This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Soochow University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Zhongjian Cai in Selenium-Containing Compounds
Introduction
Zhongjian Cai is a notable inventor based in Suzhou, China. He has made significant contributions to the field of chemistry, particularly in the development of selenium-containing compounds. His innovative work has implications for drug development and various biological applications.
Latest Patents
Zhongjian Cai holds a patent for a "Polysubstituted selenium-containing cyclopent(hex)ene skeleton derivative and synthesis method thereof." This invention provides a novel approach to synthesizing polysubstituted selenium-containing cyclopent(hex)ene skeleton derivatives using a one-pot method. The process involves an arylacetylene compound and an unsaturated selenide reagent, facilitated by a free radical initiator. The synthesis method is characterized by its simplicity, efficiency, and the absence of metal catalysts, making it a sustainable option for producing complex compounds.
Career Highlights
Zhongjian Cai is affiliated with Soochow University, where he conducts research and contributes to the academic community. His work focuses on the synthesis of compounds that exhibit biological activity against various ailments, including tumors and infections. The compounds he develops have broad application prospects in the pharmaceutical industry.
Collaborations
Zhongjian Cai has collaborated with esteemed colleagues such as Shunjun Ji and Dianliang Wang. These partnerships enhance the research output and foster innovation in their respective fields.
Conclusion
Zhongjian Cai's contributions to the field of chemistry, particularly through his patented innovations, highlight the importance of sustainable and efficient synthesis methods in drug development. His work continues to pave the way for advancements in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile